Ribavirin Powder, For Solution
Product Images NDC 68682-019

2 FDA label images from Oceanside Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ribavirin (NDC 68682-019). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oceanside Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

541adf1b-figure-01 (36b43bbc 8b1d 4253 99f8 31d24bad5d4a 01)

541adf1b-figure-01 (36b43bbc 8b1d 4253 99f8 31d24bad5d4a 01)
Chemical structure of Ribavirin showing its molecular arrangement including nitrogenous bases and sugar moieties represented by standard chemical bonds and atoms.*
FDA Label Image

Carton (Image 01)

Carton (Image 01)
Ribavirin for Inhalation Solution, USP 6 grams powder for solution carton by Oceanside Pharmaceuticals. The sterile lyophilized powder is for administration by aerosol inhalation only, packaged as one 6 g vial. The label includes dosage instructions, storage conditions, manufacturer and distributor details, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.